Sectors
AstraZeneca is a pharmaceutical and biotechnology company focusing on oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation products. It is also known for developing the Oxford–AstraZeneca Covid-19 vaccine. The company makes occasional investments in US, European and Asia-based drug developers from series A stage onwards, and had previously invested out of a $400m venture firm called MedImmune Ventures for over a decade from 2002.
Cambridge, UK
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
